Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by HighSkies2019on Nov 03, 2022 6:47pm
237 Views
Post# 35071345

Is This Stk Finished ?

Is This Stk Finished ?Hey Paul whats your honest take on this stk ...has everyone just accepted this as a loss without questioning .... its coming up to 4 mos and no one seems to know anything....Is facebook site still running on this stk cause it sounded like some were heavily invested...have you spoken to Drew what his thoughts are since he seemed to have some direct connections....heard a little noise that possible buyout....stk on U.S side had the most activity Aug to Sept highest price till it dropped to zero since early spring...not sure if someone was dumping stk cause price action seemed odd...after reading profiles on linkedin makes me pause with more questions if this just falls flat ....asking you Paul because you seem to be the only one that still keeps an eye on this board and imput.... I see the short qty was cleaned up before halt like they knew it was coming....this went from months of a long waited phase 1 start in nr to falling off the cliff with no explanation.....I understand the halt is about no funds to pay the neccessities....but wasn't the TSX looking at the bank account  to have sufficient funds for 6 mos blah blah blah...K I am done lol thx
<< Previous
Bullboard Posts
Next >>